These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20511291)

  • 21. Toxicity to early life stages and an estrogenic effect of a bisphenol A metabolite, 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene on the medaka (Oryzias latipes).
    Ishibashi H; Watanabe N; Matsumura N; Hirano M; Nagao Y; Shiratsuchi H; Kohra S; Yoshihara S; Arizono K
    Life Sci; 2005 Oct; 77(21):2643-55. PubMed ID: 15961118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor binding characteristics of the endocrine disruptor bisphenol A for the human nuclear estrogen-related receptor gamma. Chief and corroborative hydrogen bonds of the bisphenol A phenol-hydroxyl group with Arg316 and Glu275 residues.
    Liu X; Matsushima A; Okada H; Tokunaga T; Isozaki K; Shimohigashi Y
    FEBS J; 2007 Dec; 274(24):6340-51. PubMed ID: 18005256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of a novel bacterium, Sphingomonas bisphenolicum strain AO1, that degrades bisphenol A.
    Oshiman K; Tsutsumi Y; Nishida T; Matsumura Y
    Biodegradation; 2007 Apr; 18(2):247-55. PubMed ID: 16821103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells.
    Letcher RJ; Sanderson JT; Bokkers A; Giesy JP; van den Berg M
    Toxicol Appl Pharmacol; 2005 Dec; 209(2):95-104. PubMed ID: 15907334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of endocrine disrupting substance on estrogen receptor gene transcription in dialysis patients.
    Kanno Y; Okada H; Kobayashi T; Takenaka T; Suzuki H
    Ther Apher Dial; 2007 Aug; 11(4):262-5. PubMed ID: 17661831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo estrogenic activity of chlorinated derivatives of bisphenol A.
    Takemura H; Ma J; Sayama K; Terao Y; Zhu BT; Shimoi K
    Toxicology; 2005 Feb; 207(2):215-21. PubMed ID: 15596252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach.
    Teeguarden JG; Waechter JM; Clewell HJ; Covington TR; Barton HA
    Toxicol Sci; 2005 Jun; 85(2):823-38. PubMed ID: 15746009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Products of aqueous chlorination of bisphenol A and their estrogenic activity.
    Hu JY; Aizawa T; Ookubo S
    Environ Sci Technol; 2002 May; 36(9):1980-7. PubMed ID: 12026981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogenicity and acute toxicity of selected anilines using a recombinant yeast assay.
    Hamblen EL; Cronin MT; Schultz TW
    Chemosphere; 2003 Aug; 52(7):1173-81. PubMed ID: 12820998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of a yeast estrogen screen in non-biomarker species Varicorhinus barbatulus fish with two estrogen receptor subtypes to assess xenoestrogens.
    Fu KY; Chen CY; Chang WM
    Toxicol In Vitro; 2007 Jun; 21(4):604-12. PubMed ID: 17258427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ring nitrogen-substituted non-steroidal estrogens: pyridine and pyrimidine analogs of the phenol in deoxyhexestrol experience resonance constraints on preferred ligand conformation.
    De Angelis M; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5835-9. PubMed ID: 15501051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells.
    Tamir S; Eizenberg M; Somjen D; Stern N; Shelach R; Kaye A; Vaya J
    Cancer Res; 2000 Oct; 60(20):5704-9. PubMed ID: 11059763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative structure-activity relationships for estrogen receptor binding affinity of phenolic chemicals.
    Hu JY; Aizawa T
    Water Res; 2003 Mar; 37(6):1213-22. PubMed ID: 12598185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weak estrogenic transcriptional activities of Bisphenol A and Bisphenol S.
    Grignard E; Lapenna S; Bremer S
    Toxicol In Vitro; 2012 Aug; 26(5):727-31. PubMed ID: 22507746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Towards bisphenols without hormonal effects].
    Balaguer P; Delfosse V; Grimaldi M; Bourguet W
    Med Sci (Paris); 2013 Jan; 29(1):14-7. PubMed ID: 23351685
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relationship between structure of chemical substances and their affinity to estrogen receptors].
    Nishimura T; Kaneko Y; Hirakawa E; Ando M; Nishikawa J; Nishihara C
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2003; (121):100-3. PubMed ID: 14977008
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
    Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
    J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogenic effects of leachates from industrial waste landfills measured by a recombinant yeast assay and transcriptional analysis in Japanese medaka.
    Kamata R; Shiraishi F; Nakajima D; Kageyama S
    Aquat Toxicol; 2011 Jan; 101(2):430-7. PubMed ID: 21216354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity.
    Terasaka S; Inoue A; Tanji M; Kiyama R
    Toxicol Lett; 2006 May; 163(2):130-41. PubMed ID: 16280211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrated "4-phase" approach for setting endocrine disruption screening priorities--phase I and II predictions of estrogen receptor binding affinity.
    Shi L; Tong W; Fang H; Xie Q; Hong H; Perkins R; Wu J; Tu M; Blair RM; Branham WS; Waller C; Walker J; Sheehan DM
    SAR QSAR Environ Res; 2002 Mar; 13(1):69-88. PubMed ID: 12074393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.